TOXISTRATEGY
Nonclinical Safety & Toxicology Consulting
What we specialize in:
Nonclinical Safety +
Toxicology
Nonclinical development of assets from discovery to clinic, including overall toxicology strategy, protocol development, study execution and monitoring, and reporting.
Regulatory
Strategic planning and authoring of regulatory documents, including INDs, CTAs, IBs, BBs, and the like.
SEND Datasets
Oversight of SEND datasets including dataset requirements, review and submission
Who we are:
Dessi McEntee, MS, DABT
Owner + Consultant
Dessi is a board-certified toxicologist whose unique combination of expertise puts her in the top 1% of nonclinical safety professionals in the industry. She has amassed over a decade of extensive experience in the exploratory and GLP nonclinical sciences of the pharmaceutical and biotech industries, and has championed the advancement of numerous critical medicines to the clinic through successful leadership of Toxicology, Safety Pharmacology and DART strategies related to both small and large molecule therapeutics. Dessi has been the toxicologist at numerous different startups and is batting a thousand in regulatory submissions.
Whatever your needs are to bring your game-changing therapeutic to the clinic, Dessi is not only able to meet them but exceed them.
Get in touch:
Snail Mail
160 Alewife Brook Pkwy #1013
Cambridge, MA 02138
Copyright © 2022 Toxistrategy LLC
All rights reserved.